#United States #investor conference #San Rafael #biotechnology #BioMarin

BioMarin Pharmaceutical Inc. to Attend Key Investor Conferences

BioMarin Pharmaceutical Inc., listed as NASDAQ: BMRN, has made a significant announcement regarding its upcoming participation in several investor conferences scheduled for November. These events represent a vital platform for the biotech company to share its vision and advancements in treatments for rare diseases.

Upcoming Conference Dates and Details

The corporate management team at BioMarin will be presenting at three notable conferences:
1. Stifel Healthcare Conference on November 11 at 3:20 PM EST
2. UBS Global Biopharma Conference on November 16 at 9:20 AM GMT
3. Jefferies Global Healthcare Conference on November 17 at 11:30 AM GMT

For those interested in the discussions, BioMarin will provide a live audio webcast of each presentation. Investors and stakeholders can tune into these discussions via BioMarin’s investor relations website. An archived version of the presentations will also be made available for a limited time post-conference, ensuring that those unable to attend the live sessions still have access to the valuable information shared.

About BioMarin

Founded in 1997 and based in San Rafael, California, BioMarin has established itself as a leading entity in the realm of biotechnology, particularly focusing on rare genetic diseases. The company has developed nine commercial therapies, demonstrating a rich history of innovation and commitment to producing effective treatments. BioMarin employs a unique approach to drug development, emphasizing the potential of genetic science. Their efforts target medicines that bring transformative benefits to patients with genetically defined conditions.

BioMarin aims to expand its therapeutic portfolio continuously, with a robust pipeline of clinical and preclinical developments that promise to advance the standard of care for patients who previously had limited options.

With established therapies and ongoing innovations, BioMarin is dedicated to changing the lives of individuals dealing with rare diseases, having already made a significant mark in this niche area of medicine.

Looking Forward

As BioMarin gears up for these pivotal conferences, industry analysts and investors alike will be closely monitoring the presentations for insights into the company’s future endeavors and strategic developments. The upcoming month represents not only an opportunity for BioMarin to showcase its advancements but also to reaffirm its commitment to rare disease treatment solutions.

For more information about BioMarin and its ongoing projects, interested individuals can visit www.biomarin.com.